Edition:
United States

Zhejiang Huahai Pharmaceutical Co Ltd (600521.SS)

600521.SS on Shanghai Stock Exchange

21.66CNY
30 Mar 2017
Change (% chg)

¥0.04 (+0.19%)
Prev Close
¥21.62
Open
¥21.63
Day's High
¥21.87
Day's Low
¥21.55
Volume
5,798,068
Avg. Vol
5,241,377
52-wk High
¥27.49
52-wk Low
¥19.52

Latest Key Developments (Source: Significant Developments)

Zhejiang Huahai's unit to buy Par Pharmaceutical's factory in North Carolina
Tuesday, 6 Dec 2016 04:10am EST 

Zhejiang Huahai Pharmaceutical Co Ltd <600521.SS> :Says unit Prinston Pharmaceutical in deal to buy Par Pharmaceutical's factory in North Carolina's Charlotte for $14 million.  Full Article

Zhejiang Huahai Pharmaceutical gets nod for clinic trial
Thursday, 3 Nov 2016 01:38am EDT 

Zhejiang Huahai Pharmaceutical Co Ltd <600521.SS>:Says it gets China Food and Drug Administration's approval for clinic trial of a capsule used for treatment of depression.  Full Article

Zhejiang Huahai Pharmaceutical to set up medical health investment management JV
Friday, 14 Oct 2016 04:22am EDT 

Zhejiang Huahai Pharmaceutical Co Ltd <600521.SS>: Says it to set up a medical health investment management JV with a Shanghai-based fund management firm .Says the co to hold 50 percent stake in the JV.  Full Article

Zhejiang Huahai Pharmaceutical passes FDA approval
Monday, 15 Aug 2016 10:30pm EDT 

Zhejiang Huahai Pharmaceutical Co., Ltd. <600521.SS>: Says it receives approval for its voriconazole tablets from U.S Food and Drug Administration .Says company will be able to sell its voriconazole tablets in the United States after receiving the FDA approval.  Full Article

Zhejiang Huahai Pharmaceutical to transfer stake in Vivo Panda Fund to unit
Wednesday, 3 Aug 2016 10:08pm EDT 

Zhejiang Huahai Pharmaceutical Co., Ltd. <600521.SS>:Says it plans to transfer 9.97 percent stake in Vivo Panda Fund to its HK-based wholly-owned unit, for $ 10 million.  Full Article

Zhejiang Huahai Pharmaceutical adjusts private placement plan
Monday, 6 Jun 2016 11:37pm EDT 

Zhejiang Huahai Pharmaceutical Co., Ltd. <600521.SS> : Says it amends the private placement plan due to dividend payment .Says new plan is to issue up to 19.6 million new shares at 15.44 yuan per share, for 302.6 million yuan in total.  Full Article

ZHEJIANG HUAHAI PHARMACEUTICAL says 2015 dividend payment date
Monday, 30 May 2016 11:52pm EDT 

ZHEJIANG HUAHAI PHARMACEUTICAL <600521.SS> CO.,LTD: Says it will pay a cash dividend of 2 yuan (before tax) per 10 shares and use additional paid-in capital to distribute 3 new share for every 10 shares, to shareholders of record on June 3 for 2015 .Says the company's shares will be traded ex-right and ex-dividend on June 6 and the dividend will be paid on June 6.  Full Article

Zhejiang Huahai Pharmaceutical passes FDA approval
Friday, 20 May 2016 01:50am EDT 

Zhejiang Huahai Pharmaceutical Co., Ltd. <600521.SS> : Says it receives approval for its olmesartan medoxomil and hydrochlorothiazide tablets from U.S Food and Drug Administration .Says company will be able to sell this medicine in the United States after receiving the FDA approval.  Full Article

Zhejiang Huahai Pharmaceutical announces 2015 dividend payment
Monday, 18 Apr 2016 08:00pm EDT 

Zhejiang Huahai Pharmaceutical Co Ltd:To it use undistributed profits to pay a cash dividend of 2 yuan (pre-tax) per 10 shares to shareholders for 2015.To it use additional paid-in capital to distribute three new shares for every 10 shares.  Full Article

Zhejiang Huahai Pharmaceutical to provide 150 mln yuan loan guarantee for unit
Tuesday, 22 Mar 2016 08:00pm EDT 

Zhejiang Huahai Pharmaceutical Co Ltd:Says it to provide loan guarantee of up to 150 million yuan for its unit, a pharmaceutical firm.Says loan guarantee with a term of three years.  Full Article

More From Around the Web

BRIEF-Zhejiang Huahai Pharmaceutical unit gets FDA approval

* Says its unit Prinston Pharmaceutical, Inc received U.S FDA approval for a broad spectrum antibiotic tablet